Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126463) titled 'The Role of Gut Microbiota Composition and Metabolite Changes in the Pathogenesis of Vitiligo' on June 9.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Luoyang Central Hospital
Condition:
Vitiligo
Intervention:
Vitiligo group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-10
Target Sample Size: Vitiligo group:30;Healthy control group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=319367
Disclaimer: Curated by HT Syndication....